Search

Candid conversations cover a wide range of topics for cancer patients and caregivers.

… Thursday, December 3, 2020 A cancer diagnosis is daunting, and while rapid fire advances in diagnosis, treatment, and research hold much promise, many patients find sorting through an explosion of online information challenging and confusing. Diane Reidy-Lagunes, MD , and colleagues offer guidance, support

Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1.

… Wednesday, February 8, 2012 Summary Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1. For the first time, Memorial Sloan Kettering investigators have revealed the three-dimensional shape of a protein called K2P1

The advent of hepatic arterial infusion chemotherapy (HAI) for treating patients with resectable colorectal liver metastases has increased survival outcomes to previously unimaginable levels. However, questions remain about the effectiveness of its use in patients with initially unresectable colorectal liver metastases.

… Friday, August 2, 2019 The advent of hepatic arterial infusion chemotherapy (HAI) for treating patients with resectable colorectal liver metastases has increased survival outcomes to previously unimaginable levels . However, questions remain about the effectiveness of its use in patients with initially

New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how changes to “helper” proteins drive cancer cell survival; develops a new model for investigating lung cancer metastasis; and uses AI to improve outcome predictions in sarcoma.

… Wednesday, November 6, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health

Meghan Winston chose Memorial Sloan Kettering Cancer Center to surgically remove her stomach—called a total gastrectomy—to protect against a deadly form of stomach cancer caused by a rare mutation in the CDH1 gene.

… Wednesday, July 13, 2022 Meghan and Ryan Meghan Winston (right) with her fiancée Ryan Ferri. Meghan’s stomach was surgically removed at Memorial Sloan Kettering Cancer Center, to prevent the high risk she would develop a deadly stomach cancer due to a rare genetic mutation called CDH1. “I was scared

According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan- Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly set the disease apart not only from other types of ovarian cancer, but from other solid tumors as well.

… Wednesday, June 29, 2011 According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer , researchers from Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly

Find answers about rectal bleeding, including hemorrhoids and cancer, from an MSK specialist.

… Wednesday, March 4, 2026 If you notice blood in your stool or when you wipe, it’s natural to feel worried — and maybe a little embarrassed to tell anyone, even your doctor. But it’s important to recognize when something isn’t right and to know when you should speak to a healthcare provider.  “Talking

A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials. The piece was published in the April 19, 2022, “The Future of Cancer Research” special Focus edition of the journal Nature Medicine.

… Thursday, April 21, 2022 A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials

After graduate student Irene Dimatulac was diagnosed with osteosarcoma in her knee, treatment at MSK — and support from MSK’s Adolescent and Young Adult Program — allowed her to get back to her life.

… Thursday, July 29, 2021 It was Valentine’s Day in 2020 when Irene Dimatulac learned she had bone cancer in her left knee. “I’d been having pain for a few years, but it finally got to the point of not being manageable,” says the avid rock climber and speech pathology graduate student, who was 25 years

Después de que a la estudiante de posgrado Irene Dimatulac le diagnosticaran osteosarcoma en la rodilla, el tratamiento en MSK —y el apoyo del Programa para Adolescentes y Adultos Jóvenes de MSK— le permitieron volver a su vida.

… Thursday, July 29, 2021 Irene Dimatulac se enteró de que tenía cáncer de hueso en la rodilla izquierda el Día de San Valentín de 2020. “Había tenido dolor durante unos años, pero finalmente llegó al punto de que sentía que no lo podía manejar”, dice la escaladora entusiasta y estudiante de posgrado en